Cue Health
Building a business on pandemic demand without a diversification plan is existential risk.
2010 → 2023
$600M+
Healthcare/Diagnostics
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2010
Cue Health founded to build molecular diagnostics
2021
Revenue reaches $481M from COVID testing
2022
COVID testing demand drops sharply
2023
Files for bankruptcy as revenue collapses
Root Causes
Cue Health built a molecular diagnostic testing device for COVID-19 that offered lab-quality results at home. Revenue exploded to $481M in 2021 during the pandemic. But when COVID testing demand evaporated in 2022-2023, Cue's revenue collapsed and the company couldn't pivot its technology to other diagnostics fast enough. Cue filed for bankruptcy in 2023, unable to sustain operations on declining revenue.
Sources & References
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Cue Health.